Metabolic correlates of levodopa response in Parkinson's disease.
about
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET studyParkinson's disease tremor-related metabolic network: characterization, progression, and treatment effectsInflammation in depression: is adiposity a cause?The Human Experience with Intravenous LevodopaFunctional neuroimaging in Parkinson's diseasePsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorNeuroimaging and therapeutics in movement disorders.Functional imaging in Huntington's disease.Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.FDG PET in the Evaluation of Parkinson's Disease.Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depressionThe metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration.Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.Accounting for movement increases sensitivity in detecting brain activity in Parkinson's diseaseDopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's diseaseAsymmetrical effect of levodopa on the neural activity of motor regions in PDCovariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performanceMotor matters: tackling heterogeneity of Parkinson's disease in functional MRI studiesDissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.Effects of levodopa on regional cerebral metabolism and blood flowChanges in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.Network modulation in the treatment of Parkinson's diseaseCommon and unique responses to dopamine agonist therapy and deep brain stimulation in Parkinson's disease: an H(2)(15)O PET study.Neuroimaging of Parkinson's disease and atypical parkinsonism.Abnormal metabolic brain networks in a nonhuman primate model of parkinsonismMetabolic brain networks in translational neurology: concepts and applications.Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.The assessment of neurological systems with functional imaging.Metabolic changes in DYT11 myoclonus-dystonia.Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.Technology insight: imaging neurodegeneration in Parkinson's disease.Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neuronsMulticlass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesiaLow putamen activity associated with poor reward sensitivity in childhood chronic fatigue syndrome.Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory.Functional imaging of cognitive impairment in Parkinson's disease.
P2860
Q21134536-482CE011-373D-4134-91E6-457D6288FEECQ24631118-38FF4B94-DD4B-4477-B0A1-4E159A96A65FQ24635451-BB1C79DE-240D-43EC-B864-11638A22A53AQ26771516-51139FC3-F022-470C-BB3A-816F113E3500Q27013767-445B73CC-CDF4-4BE2-830D-1EF564288681Q27694728-57BE9FCA-8EE9-40E6-89C0-5DCA4E5E2BD2Q30989947-3374CE21-4070-4212-966A-EE8395BA22F8Q33403110-AE778E80-39CF-4BE7-9EEA-D57B773F858DQ33504970-CC5CB9C7-02D4-4475-A186-71779F985ED3Q34035765-93B82A57-B579-4E6F-8206-FA035DB56DFBQ34090453-CD2182DF-6E8C-4A94-B55F-066BD097E150Q34096185-C2AF0DD6-FF76-4FEC-91A3-0376D58E2E03Q34165820-E0B2B29D-B96F-4DD3-AC0D-EAE0EED8E7F0Q34260096-230C0F3D-DC8E-4992-B734-118666EB540CQ34279848-C37ED2E8-7739-408A-B36E-362D5BEE50CBQ34450348-1F020A84-DF1E-4C9A-866C-BAF220670B1EQ34518966-8A40065F-85AE-4327-98D9-4F6F403E5CF9Q34589859-7A323B0C-7A60-4513-B220-1B9B48C60FD9Q34770504-2E38B356-13D0-484C-80A8-162B645E26B8Q35040119-464C7858-549D-4E13-8422-327BF05D2A35Q35172603-666534A9-D7BA-4610-B28D-C9771FA5849EQ35679727-8CC5B3B9-F001-4AB4-84F0-1639A8D377DDQ35683286-4450071B-35E6-4135-B4A3-613F63C874D2Q35694166-004EAC6C-F380-4728-993B-170E3C180D8FQ35748449-9452A95E-FCCD-4E1B-AFD9-81074CFA587BQ35817240-1A4B6362-D8E2-471B-ADF1-7EB2CD8B9EECQ35866836-59050F14-7E85-42D2-A2BC-29C18A80E6CDQ36041821-CAC44C94-F0E1-41B2-ADBA-10D68AC0B0ECQ36198554-625B19CE-7434-406F-BA2F-C08747B1A06EQ36561279-98165005-0534-46C5-9B5A-C9C3AA8A4A50Q36659593-3536C963-1EA2-4686-B768-4B77E723FE80Q36749923-DF9F1AA0-0B75-42A3-87DF-0C97BAD1E7C6Q37125936-23A9CA1A-1EF7-4D47-9693-C0EB4418E032Q37180671-88DF90C9-AB12-4BD0-B1BD-333F6BCFA2ECQ37185684-49CBF17D-0AFD-4923-89C0-3FF80FFB0B32Q37277039-88C97DC0-D9AA-4440-9474-C5FEF9726B51Q37298975-D2DF9111-198D-40D6-84C0-AE6378A3275BQ37351319-5B24522F-E5BD-4407-817C-DEAB56132F41Q37534434-744C4DE8-DB47-40BC-9113-081590263C18Q37781045-59774616-5170-49B9-94DB-25A9EF821AA0
P2860
Metabolic correlates of levodopa response in Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Metabolic correlates of levodopa response in Parkinson's disease.
@en
Metabolic correlates of levodopa response in Parkinson's disease.
@nl
type
label
Metabolic correlates of levodopa response in Parkinson's disease.
@en
Metabolic correlates of levodopa response in Parkinson's disease.
@nl
prefLabel
Metabolic correlates of levodopa response in Parkinson's disease.
@en
Metabolic correlates of levodopa response in Parkinson's disease.
@nl
P2093
P50
P356
P1433
P1476
Metabolic correlates of levodopa response in Parkinson's disease.
@en
P2093
P304
P356
10.1212/WNL.57.11.2083
P407
P577
2001-12-01T00:00:00Z